The deal priced below last closing price of $5.04. ThinkEquity is acting as sole book running manager for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BCTX:
- BriaCell Therapeutics Announces Public Offering to Fuel Growth
- BriaCell announces common stock offering, no amount given
- BriaCell Therapeutics trading resumes
- BriaCell Therapeutics trading halted, volatility trading pause
- BriaCell’s Bria-OTS™ Shows Promising Results in Resolving Breast Cancer Lung Metastasis